House Rx is a Healthtech company based in San Francisco, CA. It has raised $100M in total funding. Latest round: Series B.
House Rx funding overview
House Rx is a Healthtech company based in San Francisco, CA. House Rx has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2025. The round record for House Rx runs through 2025; nothing later has been disclosed. Investors on record include New Enterprise Associates (NEA), Town Hall Ventures, LRVHealth, First Round Capital, Bessemer Venture Partners, Silicon Valley Bank. 6 distinct backers are named across the disclosed rounds.
House Rx at a glance
Total raised
$100M
Latest round
Series B
Latest round date
November 2025
Industry
Healthtech
Headquarters
San Francisco, CA
Notable investors
New Enterprise Associates (NEA), Town Hall Ventures, LRVHealth, First Round Capital, Bessemer Venture Partners, Silicon Valley Bank
Frequently asked about House Rx funding
How much has House Rx raised?
House Rx has raised $100M in total disclosed funding across the rounds on record.
Who has invested in House Rx?
New Enterprise Associates (NEA), Town Hall Ventures, LRVHealth, First Round Capital, Bessemer Venture Partners, Silicon Valley Bank are named among the investors backing House Rx.
What was the latest House Rx funding round?
The most recent disclosed round is a Series B, announced in November 2025.
Where is House Rx based?
House Rx is based in San Francisco, CA.
What sector does House Rx operate in?
House Rx is tracked under Healthtech from San Francisco, CA, with $100M in disclosed funding.
When did House Rx last raise?
The last disclosed House Rx round closed in November 2025 at Series B.
We update the House Rx record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Healthtech companies in San Francisco and their backers are listed below.
